High dose of simvastatin normalizes postprandial remnant-like particle response in patients with heterozygous familial hypercholesterolemia

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 11, 2000, Pages 2422-2427

  Twickler, Th B ^a   Dallinga Thie, G M ^a   De Valk, H W ^a   Schreuder, P C N J ^a   Jansen, H ^b   Cabezas, M Castro ^a   Erkelens, D W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Heterozygous familial hypercholesterolemia; Remnant lipoproteins; Simvastatin

Indexed keywords

CHYLOMICRON; LIPOPROTEIN; RETINOL; SIMVASTATIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG MEGADOSE; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; HETEROZYGOTE; HUMAN; LIPOPROTEIN METABOLISM; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL;

EID: 0033759134     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.11.2422     Document Type: Article

References (45)

1. Plasma TG is a risk factor for cardiovascular disease independent of high density lipoprotein cholesterol: A meta analyses of population based prospective studies
2. Plasma triglyceride level and mortality from cardiovascular disease
3. Chylomicrons and chylomicron remnants in coronary artery disease: A case control study
4. Relation of triglyceride metabolism and coronary artery disease
5. Impaired chylomicron remnant clearance in familial combined hyperlipidemia
6. Postprandial lipoproteins and progression of coronary atherosclerosis
7. Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease
8. Postprandial lipaemia in familial hypercholesterolemia: Clinical and metabolic significance
9. Chylomicron-remnant clearance in homozygote and heterozygote Watanabe-heritable-hyperlipidaemic rabbits is defective: Lack of evidence for an independent chylomicronremnant receptor
10. Characterization of the estrogen-induced lipoprotein receptor of rat liver
11. Use of an anti-low density lipoprotein receptor antibody to quantify the role of the LDL-receptor in the removal of chylomicron remnants in the mouse in vivo
12. Delayed chylomicron remnant clearance in subjects with heterozygous familial hypercholesterolemia
13. Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects
14. Low density lipoprotein receptor-related protein mediates the uptake of cholesteryl esters derived from apolipoprotein E-enriched lipoproteins
15. Postprandial plasma vitamin A metabolism in humans: Reassessment of the use of plasma retinyl esters as marker for intestinally derived chylomicrons and their remnants
16. Contribution of apo B-48 and apo B-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentrations of TRL-triglycerides and retinyl esters
17. Fat feeding increases size, but not number, of chylomicrons produced by the small intestine
18. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100
19. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apoB-100 and anti apo A-I immunoaffinity mixed gels
20. Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma
21. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors and hepatic apolipoprotein B secretion
22. Postprandial lipid metabolism
23. Familial hypercholesterolemia
24. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifugation
25. Separation of plasma lipoproteins by density-gradient ultracentrifugation
26. Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure
27. Apolipoprotein E2/E3/E4 genotyping with agarose gels
28. Hepatic lipase and lipoprotein lipase are not major determinants of the low density lipoprotein subclass pattern in human subjects with coronary heart disease
29. An immunochemical method for the selective measurements of two triglyceride lipases in human postheparin plasma
30. Chylomicron clearance in normal and hyperlipidemic men
31. Different patterns of postprandial lipoprotein metabolism in normal and type IIa, type III, and type IV hyperlipoproteinemics: Effects of treatment with cholestyramine and gemfibrozil
32. Protocol for the study of the metabolism of retinyl esters in plasma lipoproteins during postprandial lipemia
33. Homozygous familial hypercholesterolemia: A paradigm for phenotypic variation
34. Postprandial dyslipidemia: New opportunities for prevention of coronary disease?
35. Relative roles of the LDL receptor, the LDL receptor-like protein, and hepatic lipase in chylomicron remnant removal by the liver
36. Receptor and non-receptor mediated uptake of chylomicron remnants by the liver
37. Remnant lipoprotein metabolism: Key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E
38. Metabolism of lipoprotein remnants in humans: Studies during intestinal infusion of fat and cholesterol in subjects with varying expression of the low density lipoprotein receptor
39. Chylomicron remnant turnover in humans: Evidence for margination of chylomicrons and poor conversion of larger to smaller chylomicron remnants
40. Apolipoprotein B-48 and retinyl palmitate are not equivalent markers of postprandial intestinal lipoproteins
41. Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo
42. Endocytotic mechanism for uptake and metabolism of chylomicron remnants in the liver
43. Remnant-like particle cholesterol levels in patients with dysbetalipoproteinemia or coronary artery disease
44. Remnant-like particles and restenosis of coronary arteries after PTCA
45. Serum apolipoproteins in heterozygous familial hypercholesterolemia